Combination of tacrolimus, methotrexate, and methylprednisolone prevents acute but not chronic graft-versus-host disease in unrelated bone marrow transplantation-Reference-Cited by-同舟云学术

Combination of tacrolimus, methotrexate, and methylprednisolone prevents acute but not chronic graft-versus-host disease in unrelated bone marrow transplantation

Published:2002-07 Issue:2 Volume:74 Page:236-243
ISSN:0041-1337
Container-title:Transplantation
language:en
Short-container-title:Transplantation

Author:

Ogawa Hiroyasu,Soma Toshihiro,Hosen Naoki,Tatekawa Toyoshi,Tsuboi Akihiro,Oji Yusuke,Tamaki Hiroya,Kawakami Manabu,Ikegame Kazuhiro,Murakami Masaki,Fujioka Tatsuya,Kim Eui Ho,Oka Yoshihiro,Sugiyama Haruo

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Transplantation

Reference30 articles.

1. Bone Marrow Transplants from Unrelated Donors for Patients with Chronic Myeloid Leukemia

2. The outcome of matched unrelated donor bone marrow transplantation in patients with hematologic malignancies using molecular typing for donor selection and graft-versus-host disease prophylaxis regimen of cyclosporine, methotrexate, and prednisone

3. Tacrolimus and minidose methotrexate for prevention of acute graft- versus-host disease after matched unrelated donor marrow transplantation

4. FK506 augments activation-induced programmed cell death of T lymphocytes in vivo.

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Unmanipulated haploidentical stem cell transplantation using low-dose ATG and steroid for high-risk diseases;Journal of Hematopoietic Cell Transplantation;2020

2. Prophylactic and therapeutic treatment of graft-versus-host disease in Japan;International Journal of Hematology;2015-04-12

3. Allogeneic stem cell transplantation as treatment for heavily treated, refractory acute graft-versus-host disease after HLA-mismatched stem cell transplantation;Experimental Hematology;2011-08

4. Transplantation immunology: Solid organ and bone marrow;Journal of Allergy and Clinical Immunology;2010-02

5. Unmanipulated HLA 2-3 antigen–mismatched (haploidentical) bone marrow transplantation using only pharmacological GVHD prophylaxis;Experimental Hematology;2008-01